mechanism glp 1 receptor agonist of action of GLP-1 agonists – My Endo Consult GLP-1 Receptor Agonists and Myocardial

Gerstein, R.R

It is important to note that, in the other large type 2 diabetes cardiovascular outcome trials, there were no statistically significant associations with the use of GLP-1/GIP agonists and negative eye outcomes

Diabetes can also put you at a higher risk for hair loss if you experience rapid, significant weight loss

The most common side effects are nausea, vomiting, constipation, diarrhea and heartburn

A 2025 systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders found that tirzepatide (the active ingredient in Mounjaro and Zepbound) reduced hsCRP by approximately 33% and IL-6 by approximately 18% compared to placebo across patients with and without diabetes. A growing body of research suggests this effect occurs through direct action on the NF-B pathway, a master switch of inflammation